Announcement of Meeting of the Secretary's Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030, 21255-21256 [2017-09147]
Download as PDF
21255
Federal Register / Vol. 82, No. 86 / Friday, May 5, 2017 / Notices
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
other public health related
organizations.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
responses
Total burden
hours
Ambassador Portal—New Applicants ..................................
Ambassador Portal—Updates to current Ambassador profiles ...................................................................................
156
1
156
.10
16
600
1
600
.10
60
Total ..............................................................................
756
........................
756
........................
76
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2017–09085 Filed 5–4–17; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of Meeting of the
Secretary’s Advisory Committee on
National Health Promotion and Disease
Prevention Objectives for 2030
Office of Disease Prevention
and Health Promotion, Office of the
Assistant Secretary for Health, Office of
the Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
The U.S. Department of
Health and Human Services (HHS)
announces the next federal advisory
committee meeting regarding the
development of national health
promotion and disease prevention
objectives for 2030. This meeting will be
held online via webinar and is open to
the public. The Committee will discuss
the nation’s health promotion and
disease prevention objectives and will
provide recommendations to improve
health status and reduce health risks for
the nation by the year 2030. The
SRADOVICH on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:43 May 04, 2017
Jkt 241001
Committee will advise the Secretary on
the Healthy People 2030 mission,
vision, framework, and organizational
structure. The Committee will provide
advice regarding criteria for identifying
a more focused set of measurable,
nationally representative objectives. The
Committee’s advice must assist the
Secretary in reducing the number of
objectives while ensuring that the
selection criteria identifies the most
critical public health issues that are
high-impact priorities supported by
current national data.
DATES: The Committee will meet on
June 27, 2017, from 1:00 p.m. to 5:00
p.m. Eastern Time (ET).
ADDRESSES: The meeting will be held
online via webinar. To register to attend
the meeting, please visit the Healthy
People Web site at https://
www.healthypeople.gov.
FOR FURTHER INFORMATION CONTACT:
Emmeline Ochiai, Designated Federal
Officer, Secretary’s Advisory Committee
on National Health Promotion and
Disease Prevention Objectives for 2030,
U.S. Department of Health and Human
Services, Office of the Assistant
Secretary for Health, Office of Disease
Prevention and Health Promotion, 1101
Wootton Parkway, Room LL–100,
Rockville, MD 20852, (240) 453–8280
(telephone), (240) 453–8281 (fax).
Additional information is available on
the Healthy People Web site at https://
www.healthypeople.gov.
SUPPLEMENTARY INFORMATION: The
names and biographies of the
Committee members are available at
https://www.healthypeople.gov/2020/
about/history-development/healthypeople-2030-advisory-committee.
Purpose of Meeting: Through the
Healthy People initiative, HHS leverages
scientific insights and lessons from the
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
past decade, along with new knowledge
of current data, trends, and innovations,
to develop the next iteration of national
health promotion and disease
prevention objectives. Healthy People
provides science-based, 10-year national
objectives for promoting health and
preventing disease. Since 1979, Healthy
People has set and monitored national
health objectives that meet a broad
range of health needs, encourage
collaboration across sectors, guide
individuals toward making informed
health decisions, and measure the
impact of our prevention and health
promotion activities. Healthy People
2030 health objectives will reflect
assessments of major risks to health and
wellness, changing public health
priorities, and emerging technologies
related to our nation’s health
preparedness and prevention.
Public Participation at Meeting:
Members of the public are invited to
join the online Committee meeting.
There will be no opportunity for oral
public comments during this online
Committee meeting. However, written
comments are welcome throughout the
entire development process of the
national health promotion and disease
prevention objectives for 2030 and may
be emailed to HP2030@hhs.gov.
To join the Committee meeting,
individuals must pre-register at the
Healthy People Web site at https://
www.healthypeople.gov. Participation in
the meeting is limited. Registrations will
be accepted until maximum webinar
capacity is reached and must be
completed by 9:00 a.m. ET on June 26,
2017. A waiting list will be maintained
should registrations exceed capacity,
and those individuals will be contacted
as additional space for the meeting
becomes available. Registration
questions may be directed to: Jim
E:\FR\FM\05MYN1.SGM
05MYN1
21256
Federal Register / Vol. 82, No. 86 / Friday, May 5, 2017 / Notices
Nakayama at events@
nakamotogroup.com, or (240) 672–4011.
Authority: 42 U.S.C. 217a. The Secretary’s
Advisory Committee on National Health
Promotion and Disease Prevention Objectives
for 2030 is governed by provisions of the
Federal Advisory Committee Act (FACA),
Public Law 92–463, as amended (5 U.S.C.,
App.) which sets forth standards for the
formation and use of federal advisory
committees.
Dated: May 1, 2017.
Don Wright,
Deputy Assistant Secretary for Health
(Disease Prevention and Health Promotion).
[FR Doc. 2017–09147 Filed 5–4–17; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
SRADOVICH on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
J—Career Development.
Date: June 13–14, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Tushar Deb, Ph.D.,
Scientific Review Officer, Resources &
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH 9609 Medical Center Drive,
Room 7W624, Bethesda, MD 20892–9750,
240–276–6132, tushar.deb@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Omnibus R03.
Date: June 15–16, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Ombretta Salvucci, Ph.D.,
Scientific Review Officer, Special Review
VerDate Sep<11>2014
17:43 May 04, 2017
Jkt 241001
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W264, Bethesda, MD
20892–9750, 240–276–7286, salvucco@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Clinical and Translational R21 & Omnibus
R03: SEP–9.
Date: June 19–20, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology &
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W246, Bethesda, MD 20892–9750,
240–276–5460, jfang@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Research Specialist—R50.
Date: June 22–23, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Zhiqiang Zou, MD, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W242, Bethesda, MD
20892–9750, 240–276–6372, zouzhiq@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Clinical and Translational R21 & Omnibus
R03: SEP 5.
Date: June 23, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Jennifer C Schiltz, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W264, Bethesda, MD
20892–9750, 240–276–5122, jennifer.schiltz@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI R03 &
Clinical and Translational R21: SEP–8.
Date: June 28–29, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Eduardo E Chufan, Ph.D.,
Scientific Review Officer, Research
Technology & Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W254, Bethesda, MD 20892–
9750, 240–276–7975, chufanee@mail.nih.gov.
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI R03 &
Clinical and Translational R21: SEP–1.
Date: June 28, 2017.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
2E030, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Ivan Ding, MD, Health
Scientist Administrator, Program & Review
Extramural Staff Training Office, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W534, Bethesda, MD 20892–9750,
240–276–6444, dingi@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Innovative
Molecular and Cellular Analysis.
Date: June 30, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Yasuko Furumoto, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W634, Bethesda, MD 20892–
9750, 240–276–5287, yasuko.furumoto@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; PDX
Development and Trial Centers RFA CA–17–
003 (U54) & RFA CA–17–004 (U24).
Date: July 11–12, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Timothy C. Meeker, MD,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W606, Bethesda, MD 20892–9750,
240–276–6464, meekert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Quantitative Imaging to Evaluate Response to
Cancer Therapy.
Date: July 12, 2017.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
2W030, Bethesda, MD 20892–9750
(Telephone Conference Call).
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W260, Bethesda, MD 20892–
9750, 240–276–6348, nadeem.khan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
E:\FR\FM\05MYN1.SGM
05MYN1
Agencies
[Federal Register Volume 82, Number 86 (Friday, May 5, 2017)]
[Notices]
[Pages 21255-21256]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-09147]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Announcement of Meeting of the Secretary's Advisory Committee on
National Health Promotion and Disease Prevention Objectives for 2030
AGENCY: Office of Disease Prevention and Health Promotion, Office of
the Assistant Secretary for Health, Office of the Secretary, Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The U.S. Department of Health and Human Services (HHS)
announces the next federal advisory committee meeting regarding the
development of national health promotion and disease prevention
objectives for 2030. This meeting will be held online via webinar and
is open to the public. The Committee will discuss the nation's health
promotion and disease prevention objectives and will provide
recommendations to improve health status and reduce health risks for
the nation by the year 2030. The Committee will advise the Secretary on
the Healthy People 2030 mission, vision, framework, and organizational
structure. The Committee will provide advice regarding criteria for
identifying a more focused set of measurable, nationally representative
objectives. The Committee's advice must assist the Secretary in
reducing the number of objectives while ensuring that the selection
criteria identifies the most critical public health issues that are
high-impact priorities supported by current national data.
DATES: The Committee will meet on June 27, 2017, from 1:00 p.m. to 5:00
p.m. Eastern Time (ET).
ADDRESSES: The meeting will be held online via webinar. To register to
attend the meeting, please visit the Healthy People Web site at https://www.healthypeople.gov.
FOR FURTHER INFORMATION CONTACT: Emmeline Ochiai, Designated Federal
Officer, Secretary's Advisory Committee on National Health Promotion
and Disease Prevention Objectives for 2030, U.S. Department of Health
and Human Services, Office of the Assistant Secretary for Health,
Office of Disease Prevention and Health Promotion, 1101 Wootton
Parkway, Room LL-100, Rockville, MD 20852, (240) 453-8280 (telephone),
(240) 453-8281 (fax). Additional information is available on the
Healthy People Web site at https://www.healthypeople.gov.
SUPPLEMENTARY INFORMATION: The names and biographies of the Committee
members are available at https://www.healthypeople.gov/2020/about/history-development/healthy-people-2030-advisory-committee.
Purpose of Meeting: Through the Healthy People initiative, HHS
leverages scientific insights and lessons from the past decade, along
with new knowledge of current data, trends, and innovations, to develop
the next iteration of national health promotion and disease prevention
objectives. Healthy People provides science-based, 10-year national
objectives for promoting health and preventing disease. Since 1979,
Healthy People has set and monitored national health objectives that
meet a broad range of health needs, encourage collaboration across
sectors, guide individuals toward making informed health decisions, and
measure the impact of our prevention and health promotion activities.
Healthy People 2030 health objectives will reflect assessments of major
risks to health and wellness, changing public health priorities, and
emerging technologies related to our nation's health preparedness and
prevention.
Public Participation at Meeting: Members of the public are invited
to join the online Committee meeting. There will be no opportunity for
oral public comments during this online Committee meeting. However,
written comments are welcome throughout the entire development process
of the national health promotion and disease prevention objectives for
2030 and may be emailed to HP2030@hhs.gov.
To join the Committee meeting, individuals must pre-register at the
Healthy People Web site at https://www.healthypeople.gov. Participation
in the meeting is limited. Registrations will be accepted until maximum
webinar capacity is reached and must be completed by 9:00 a.m. ET on
June 26, 2017. A waiting list will be maintained should registrations
exceed capacity, and those individuals will be contacted as additional
space for the meeting becomes available. Registration questions may be
directed to: Jim
[[Page 21256]]
Nakayama at events@nakamotogroup.com, or (240) 672-4011.
Authority: 42 U.S.C. 217a. The Secretary's Advisory Committee
on National Health Promotion and Disease Prevention Objectives for
2030 is governed by provisions of the Federal Advisory Committee Act
(FACA), Public Law 92-463, as amended (5 U.S.C., App.) which sets
forth standards for the formation and use of federal advisory
committees.
Dated: May 1, 2017.
Don Wright,
Deputy Assistant Secretary for Health (Disease Prevention and Health
Promotion).
[FR Doc. 2017-09147 Filed 5-4-17; 8:45 am]
BILLING CODE 4150-32-P